Photos from enVato
Among the top 20 companies in the world, more than two -thirds of the market value decreased.
The biopharmaceutical industry performed well in 2024. As of December 31, the market value of the top 20 biopharmaceutical companies increased by 1.7 % to 3.7 tons.
According to GlobalData data, two -thirds of these companies have declined.
The report said: “The growth of three companies exceeds 10 %: Lilly (32.4 %), Abuvi (14.8 %) and Gilyda Science (14.0 %).”
GlobalData's Business Fundamentals senior analyst Ophelia Chan said that due to policy transfer and regulatory issues, the performance of the industry reflects increasingly serious uncertainty.
Chan added: “As Trump's second term is priced at drugs, inflation trends and FDA approval have proposed concerns, the industry is facing the prospect of entering 2025.”
Join HealthCare Asia Magazine Community
Since you are here …
… You can propagate your company with us in various ways and establish contact with your customers. Our team can help you DIGHT and create advertising activities in printing and numbers on this website and printing magazines.
We can also organize real life or digital activities for you, and find ideological leader speakers and industry leaders who can become your potential partners to participate in the event. We have also carried out some awards plans, which gives you the opportunity to achieve your achievements in this year, and you can join as participants or sponsors.
Let us help you promote business through good partnership!
